[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Volitionrx Ltd (VNRX)

Volitionrx Ltd (VNRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 16,580
  • Shares Outstanding, K 8,088
  • Annual Sales, $ 1,730 K
  • Annual Income, $ -23,360 K
  • EBIT $ -22 M
  • EBITDA $ -19 M
  • 60-Month Beta 1.03
  • Price/Sales 10.54
  • Price/Cash Flow N/A
  • Price/Book N/A

Options Overview Details

View History
  • Implied Volatility 191.60% (-328.05%)
  • Historical Volatility 88.27%
  • IV Percentile 3%
  • IV Rank 1.09%
  • IV High 1,285.20% on 02/04/26
  • IV Low 179.56% on 05/06/26
  • Expected Move (DTE 2) 0.64 (27.48%)
  • Put/Call Vol Ratio 0.03
  • Today's Volume 37
  • Volume Avg (30-Day) 29
  • Put/Call OI Ratio 0.03
  • Today's Open Interest 3,343
  • Open Int (30-Day) 3,592
  • Expected Range 1.68 to 2.96

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/26
See More
  • Average Estimate $-0.70
  • Number of Estimates 2
  • High Estimate $-0.60
  • Low Estimate $-0.80
  • Prior Year $-1.20
  • Growth Rate Est. (year over year) +41.67%

Price Performance

See More
Period Period Low Period High Performance
1-Month
2.01 +15.34%
on 05/11/26
3.65 -36.44%
on 04/17/26
-1.00 (-30.04%)
since 04/10/26
3-Month
2.01 +15.34%
on 05/11/26
6.06 -61.70%
on 03/18/26
-2.38 (-50.68%)
since 02/12/26
52-Week
2.01 +15.34%
on 05/11/26
18.80 -87.66%
on 06/23/25
-7.58 (-76.56%)
since 05/12/25

Most Recent Stories

More News
VolitionRx Limited Schedules First Quarter 2026 Earnings Conference Call and Business Update

Conference call to take place on Friday, May 15 at 8:30 a.m. U.S Eastern Time

VNRX : 2.32 (+13.17%)
VolitionRx Announces Submission of Manuscript for Nu.Q® Vet Cancer Test in Cats

The publication of this study in a peer reviewed journal is expected subsequently to unlock a $5 million contractual milestone payment

VNRX : 2.32 (+13.17%)
Volition Announces Breakthrough Finger-Prick Detection of Nucleosomes; Expanding Global Market Potential for Sepsis Testing

HENDERSON, Nev. , April 29, 2026 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company, today announces a major technical milestone with the...

VNRX : 2.32 (+13.17%)
VolitionRx Announces Acceptance of Compliance Plan by NYSE American

HENDERSON, Nev. , April 23, 2026 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition" or the "Company"), a multi-national epigenetics company, announced today that on April 22, 2026,...

VNRX : 2.32 (+13.17%)
Volition Launches rNuQâ„¢ Webshop Broadening Product Range

HENDERSON, Nev. , April 20, 2026 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company, announces the launch of its rNuQ webshop offering...

VNRX : 2.32 (+13.17%)
VolitionRx Limited Announces Full Fiscal Year 2025 Financial Results and Business Update

Conference call to discuss financial and operational results scheduled for Wednesday, April 1 at 8:30 a.m. U.S. Eastern Time

VNRX : 2.32 (+13.17%)
VolitionRx Secures EUR 2.0 Million of Non-Dilutive Funding from Regional Government Agencies in Belgium

HENDERSON, Nev. , March 31, 2026 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company, has secured an additional €2.0 million (approximately...

VNRX : 2.32 (+13.17%)
Volition Announces Mayo Clinic Study Demonstrates Nu.Q® Concentrations are Elevated in Trauma Patients

Peer Reviewed Clinical Study for Nu.Q® Biomarkers Published in Shock Journal

VNRX : 2.32 (+13.17%)
Volition Announces Abstract Demonstrating Risk Stratification in Lung Cancer Presented at the European Lung Cancer Conference

HENDERSON, Nev. , March 26, 2026 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company, announces the presentation of an abstract at the European...

VNRX : 2.32 (+13.17%)
VolitionRx Limited Schedules Full Fiscal Year 2025 Earnings Conference Call and Business Update

Conference call to take place on Wednesday, April 1 at 8:30 a.m. U.S Eastern Time

VNRX : 2.32 (+13.17%)

Business Summary

Volition RX Ltd is a life sciences company engaged in developing a range of blood-based epigenetic cancer diagnostic tests. Its tests are designed to detect the nucleosome patterns that are specific to cancer in the blood, and identify some of the major nucleosome varieties that differ between cancer...

See More

Key Turning Points

3rd Resistance Point 2.70
2nd Resistance Point 2.53
1st Resistance Point 2.43
Last Price 2.32
1st Support Level 2.16
2nd Support Level 1.99
3rd Support Level 1.89

See More

52-Week High 18.80
Fibonacci 61.8% 12.39
Fibonacci 50% 10.41
Fibonacci 38.2% 8.42
Last Price 2.32
52-Week Low 2.01

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.